| Canton Christian Home | |
| 2550 Cleveland Avenue Nw, Canton, Ohio 44709 | |
| (330) 456-0004 | |
| Name | Canton Christian Home |
|---|---|
| Location | 2550 Cleveland Avenue Nw, Canton, Ohio |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 75 |
| Occupancy Rate | 84.67% |
| Medicare ID (CCN) | 366300 |
| Legal Business Name | Canton Christian Home Inc |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1982605507 |
| Organization Name | CANTON CHRISTIAN HOME, INC |
| Address | 2550 Cleveland Ave Nw, Canton, OH 44709 |
| Phone Number | 330-456-0004 |
News Archive
Hana Biosciences Inc.,, a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the first quarter ended March 31, 2010, and provided a corporate update.
The U.S. Food and Drug Administration today approved Kyprolis (carfilzomib) to treat patients with multiple myeloma who have received at least two prior therapies, including treatment with Velcade (bortezomib) and an immunomodulatory therapy. A form of blood cancer that arises from plasma cells, multiple myeloma usually grows in bone marrow, the soft, spongy tissue found inside most bones.
Young adults at risk of developing problems with addiction show key differences in an important region of the brain, according to an international team led by researchers at the University of Cambridge.
Curasan AG, a leading specialist for medical products in the field of orthobiologics, has received the market clearance of the Food and Drug Administration (FDA) and thus the authorization to market its synthetic bone regeneration material CERASORB Ortho FOAM in the United States.
For those suffering depression or anxiety, using cannabis for relief may not be the long-term answer.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Hana Biosciences Inc.,, a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the first quarter ended March 31, 2010, and provided a corporate update.
The U.S. Food and Drug Administration today approved Kyprolis (carfilzomib) to treat patients with multiple myeloma who have received at least two prior therapies, including treatment with Velcade (bortezomib) and an immunomodulatory therapy. A form of blood cancer that arises from plasma cells, multiple myeloma usually grows in bone marrow, the soft, spongy tissue found inside most bones.
Young adults at risk of developing problems with addiction show key differences in an important region of the brain, according to an international team led by researchers at the University of Cambridge.
Curasan AG, a leading specialist for medical products in the field of orthobiologics, has received the market clearance of the Food and Drug Administration (FDA) and thus the authorization to market its synthetic bone regeneration material CERASORB Ortho FOAM in the United States.
For those suffering depression or anxiety, using cannabis for relief may not be the long-term answer.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 3 |
| Total Amount of Fines in Dollars | $45184 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 3 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 7.94 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 5.21 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 63.72 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.07 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.79 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.59 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.1 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 8.75 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 93.65 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.25 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 27.33 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 24.77 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 11.26 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 62.94 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 93.3 | 82.93 |
News Archive
Hana Biosciences Inc.,, a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the first quarter ended March 31, 2010, and provided a corporate update.
The U.S. Food and Drug Administration today approved Kyprolis (carfilzomib) to treat patients with multiple myeloma who have received at least two prior therapies, including treatment with Velcade (bortezomib) and an immunomodulatory therapy. A form of blood cancer that arises from plasma cells, multiple myeloma usually grows in bone marrow, the soft, spongy tissue found inside most bones.
Young adults at risk of developing problems with addiction show key differences in an important region of the brain, according to an international team led by researchers at the University of Cambridge.
Curasan AG, a leading specialist for medical products in the field of orthobiologics, has received the market clearance of the Food and Drug Administration (FDA) and thus the authorization to market its synthetic bone regeneration material CERASORB Ortho FOAM in the United States.
For those suffering depression or anxiety, using cannabis for relief may not be the long-term answer.
› Verified 3 days ago
Hall Of Fame Rehabilitation And Nursing Center Location: 2714 13th Street Nw, Canton, Ohio 44708 Phone: (330) 456-2842 | |
Mckinley Health Care Ctr Llc Location: 800 Market Avenue North, Canton, Ohio 44702 Phone: (330) 456-1014 | |
Aultman Transitional Care Center Location: 2821 Woodlawn Avenue Nw, Canton, Ohio 44708 Phone: (330) 479-4800 | |
Glenwood Care And Rehabilitation Location: 836 West 34th Street Nw, Canton, Ohio 44709 Phone: (330) 492-7131 |